Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Withdrawn 10Completed 6Terminated 3Active not recruiting 3Unknown 1

Sponsor Class

OTHER 101NIH 5NETWORK 4INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Dermatologic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 1Melanoma 1Liver Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 183Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 53fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 39Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Radiosurgery × Clear all
NCT03924869 2025-12-11

KEYNOTE-867

Merck Sharp & Dohme LLC

Phase 3 Terminated
448 enrolled 24 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT02721056 2021-05-10

NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers

Nanobiotix

Phase 1/2 Terminated
23 enrolled
Gastrointestinal

Liver Neoplasms

NCT01973608 2016-10-31

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

EMD Serono

Phase 2 Terminated
12 enrolled 10 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡